Corrigendum to Effects of retroviral envelope-protein cleavage upon trafficking, incorporation, and membrane fusion(Virology (2010) 405(1) (214–224), (S0042682210003855), (10.1016/j.virol.2010.06.004));Effects of retroviral envelope-protein cleavage upon trafficking, incorporation, and membrane fusion

Virology

Volumn 405, Issue 1, 2010, Pages 214-224

  Apte, Swapna ^a   Sanders, David Avram ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Envelope protein; Membrane fusion; Proteolytic processing; Retrovirus; Viral incorporation

Indexed keywords

GLYCOPROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CELL SECRETION; CELL TRANSPORT; HUMAN; HUMAN CELL; MEMBRANE FUSION; MOLONEY LEUKEMIA ONCOVIRUS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN TRANSPORT; VIRUS PARTICLE;

MOLONEY MURINE LEUKEMIA VIRUS;

EID: 77955519056     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2021.10.006     Document Type: Erratum

References (58)

1. Aguilar H.C., Anderson W.F., Cannon P.M. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R peptide. J. Virol. 2003, 77(2):1281-1291.
2. Albritton L.M., Tseng L., Scadden D., Cunningham J.M. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989, 57(4):659-666.
3. Basak A., Zhong M., Munzer J.S., Chretien M., Seidah N.G. Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides. Biochem. J. 2001, 353(3):537-545.
4. Bedgood R., Stallcup M. A novel intermediate in processing of murine leukemia virus envelope glycoproteins. Proteolytic cleavage in the late Golgi region. J. Biol. Chem. 1992, 267(10):7060-7065.
5. Bosch V., Pawlita M. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol. 1990, 64(5):2337-2344.
6. Retroviruses 1997, 343-435. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. J.M. Coffin, S.H. Hughes, H.E. Varmus (Eds.).
7. Dong J.Y., Dubay J.W., Perez L.G., Hunter E. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J. Virol. 1992, 66(2):865-874.
8. Dubay J.W., Dubay S.R., Shin H.J., Hunter E. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 1995, 69(8):4675-4682.
9. Famulari N.G., Jelalian K. Cell surface expression of the env gene polyprotein of dual-tropic mink cell focus-forming murine leukemia virus. J. Virol. 1979, 30(3):720-728.
10. François Jean L.T., Molloy Sean S., Liu Gseping, Jarvis Michael A., Nelson Jay A., Thomas Gary A protein-based therapeutic for human cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(6):2864-2869.
11. Freed E.O., Risser R. The role of envelope glycoprotein processing in murine leukemia virus infection. J. Virol. 1987, 61(9):2852-2856.
12. Freed E.O., Myers D.J., Risser R. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. J. Virol. 1989, 63(11):4670-4675.
13. Fujisawa R., Masuda M. Ecotropic murine leukemia virus envelope protein affects interaction of cationic amino acid transporter 1 with clathrin adaptor protein complexes, leading to receptor downregulation. Virology 2007, 368(2):342-350.
14. Goodman L.J., Kain S.R., Firestone G.L. Trafficking of wild-type and an endoproteolytic-site mutant of the mouse mammary tumor virus glycoprotein. J. Biol. Chem. 1993, 268(4):2329-2336.
15. Granowitz C., Colicelli J., Goff S.P. Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance. Virology 1991, 183(2):545-554.
16. Guo H.G., Veronese F.M., Tschachler E., Pal R., Kalyanaraman V.S., Gallo R.C., Reitz M.S. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. Virology 1990, 174(1):217-224.
17. Henderson L.E., Sowder R., Copeland T.D., Smythers G., Oroszlan S. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 1984, 52(2):492-500.
18. Henrich S., Cameron A., Bourenkov G.P., Kiefersauer R., Huber R., Lindberg I., Bode W., Than M.E. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat. Struct. Mol. Biol. 2003, 10(7):520-526.
19. Henrich S., Lindberg I., Bode W., Than M.E. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J. Mol. Biol. 2005, 345(2):211-227.
20. Herrera C., Klasse P.J., Michael E., Kake S., Barnes K., Kibler C.W., Campbell-Gardener L., Si Z., Sodroski J., Moore J.P., Beddows S. The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles. Virology 2005, 338(1):154-172.
21. Januszeski M., Cannon P., Chen D., Rozenberg Y., Anderson W. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 1997, 71(5):3613-3619.
22. Kamps C.A., Lin Y.C., Wong P.K. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology 1991, 184(2):687-694.
23. Kayman S.C., Kopelman R., Projan S., Kinney D.M., Pinter A. Mutational analysis of N-linked glycosylation sites of friend murine leukemia virus envelope protein. J. Virol. 1991, 65(10):5323-5332.
24. Kibler K.V., Miyazato A., Yedavalli V.S.R.K., Dayton A.I., Jacobs B.L., Dapolito G., Kim S.-j., Jeang K.-T. Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection. J. Biol. Chem. 2004, 279(47):49055-49063.
25. Kleny M.P., Lathe R., Riviére Y., Dott K., Schmitt D., Girard M., Montagnier L., Lecocq J.-P. Improved antigenicity of the HIV env protein by cleavage site removal. Prot. Eng. 1988, 2(3):219-225.
26. Kubo Y., Amanuma H. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein. J. Gen. Virol. 2003, 84(8):2253-2257.
27. Kubo Y., Tominaga C., Yoshii H., Kamiyama H., Mitani C., Amanuma H., Yamamoto N. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytia formation and entry. Arch. Virol. 2007, 152(12):2169-2182.
28. Li Z., Pinter A., Kayman S. The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex. J. Virol. 1997, 71(9):7012-7019.
29. Machida C.A., Kabat D. Role of partial proteolysis in processing murine leukemia virus membrane envelope glycoproteins to the cell surface. A viral mutant with uncleaved glycoprotein. J. Biol. Chem. 1982, 257(23):14018-14022.
30. McCune J.M., Rabin L.B., Feinberg M.B., Lieberman M., Kosek J.C., Reyes G.R., Weissman I.L. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 1988, 53(1):55-67.
31. Opstelten D.J., Wallin M., Garoff H. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J. Virol. 1998, 72(8):6537-6545.
32. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(21):11400-11406.
33. Perez L.G., Hunter E. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37. J. Virol. 1987, 61(5):1609-1614.
34. Pinter A., Fleissner E. The presence of disulfide-linked gp70-p15(E) complexes in AKR murine leukemia virus. Virology 1977, 83(2):417-422.
35. Pinter A., Kopelman R., Li Z., Kayman S., Sanders D. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol- disulfide exchange enzymes. J. Virol. 1997, 71(10):8073-8077.
36. Ragheb J.A., Anderson W.F. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 1994, 68(5):3220-3231.
37. Rein A., Mirro J., Haynes J.G., Ernst S.M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 1994, 68(3):1773-1781.
38. Remacle A.G., Shiryaev S.A., Oh E.S., Cieplak P., Srinivasan A., Wei G., Liddington R.C., Ratnikov B.I., Parent A., Desjardins R., Day R., Smith J.W., Lebl M., Strongin A.Y. Substrate cleavage analysis of furin and related proprotein convertases: a comparative study. J. Biol. Chem. 2008, 283(30):20897-20906.
39. Rockwell N.C., Fuller R.S. Interplay between S1 and S4 Subsites in Kex2 protease: Kex2 exhibits dual specificity for the P4 side chain. Biochemistry 1998, 37(10):3386-3391.
40. Rockwell N.C., Fuller R.S. Specific modulation of Kex2/furin family proteases by potassium. J. Biol. Chem. 2002, 277(20):17531-17537.
41. Rockwell N.C., Thorner J.W. The kindest cuts of all: crystal structures of Kex2 and furin reveal secrets of precursor processing. Trends Biochem. Sci. 2004, 29(2):80-87.
42. Rockwell N.C., Krysan D.J., Komiyama T., Fuller R.S. Precursor processing by Kex2/Furin proteases. Chem. Rev. 2002, 102(12):4525-4548.
43. Sanders D.A. Sulfhydryl involvement in fusion mechanisms. Fusion of Biological Membranes and Related Problems 2000, 483-514. Kluwe Academic/Plenum Publishers, New York. H. Hilderson, S. Fuller (Eds.).
44. Sandrin V., Cosset F.L. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J. Biol. Chem. 2006, 281(1):528-542.
45. Sarac M.S., Cameron A., Lindberg I. The furin inhibitor hexa-d-arginine blocks the activation of pseudomonas aeruginosa exotoxin a in vivo. Infect. Immun. 2002, 70(12):7136-7139.
46. Schechter I., Berger A. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem. Biophys. Res. Commun. 1968, 32:898-902.
47. Schultz A., Rein A. Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology 1985, 145(2):335-339.
48. Sharkey C.M., North C.L., Kuhn R.J., Sanders D.A. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J. Virol. 2001, 75(6):2653-2659.
49. Shinnick T.M., Lerner R.A., Sutcliffe J.G. Nucleotide sequence of Moloney murine leukaemia virus. Nature 1981, 293(5833):543-548.
50. Steck F.T., Rubin H. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. II. Early steps of infection by RSV of cells under conditions of interference. Virology 1966, 29(4):628-641.
51. Tailor C., Kabat D. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J. Virol. 1997, 71(12):9383-9391.
52. Taylor G.M., Sanders D.A. The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol. Biol. Cell 1999, 10(9):2803-2815.
53. Taylor G.M., Sanders D.A. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain. Virology 2003, 312(2):295-305.
54. Wang H., Kavanaugh M.P., North R.A., Kabat D. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 1991, 352(6337):729-731.
55. Watanabe M., Hirano A., Stenglein S., Nelson J., Thomas G., Wong T.C. Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. J. Virol. 1995, 69(5):3206-3210.
56. Witte O.N., Wirth D.F. Structure of the murine leukemia virus envelope glycoprotein precursor. J. Virol. 1979, 29(2):735-743.
57. Witte O.N., Tsukamoto-Adey A., Weissman I.L. Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes. Virology 1977, 76(2):539-553.
58. Zavorotinskaya T., Albritton L.M. Failure to cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction. J. Virol. 1999, 73(7):5621-5629.